Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Veterinary Intravenous Solutions Market: By Product Type, By End User, and Geography
Veterinary Intravenous Solutions Market: By Product Type, By End User, and Geography
Veterinary Intravenous Solutions Market size was valued at US$ 11.8 billion in 2023 and is poised to grow at a CAGR of 8% from 2024 to 2030 owing to increase in incidence of diseases affecting animals. Veterinary Intravenous Solutions are the nutritional products that are given to the animals when they are attacked by diseases such as pancreatitis. Increasing demand for pets and companion animals, high emphasis on animal wellness and health by veterinarians are expected to propel the growth of the market. Additionally, the emphasis on food safety, increased care towards animals, increasing need for nutrition-rich food are expected to enhance the sales of the market. However the awareness regarding the uses of veterinary intravenous solutions are limited and it is expected to limit the growth of the veterinary intravenous solutions market.
Study Period
2024-2030Base Year
2023CAGR
8%Largest Market
North AmericaFastest Growing Market
Asia Paciifc
Increase in the prevalence of diseases like foot and mouth disease, anthrax, pancreatitis and other diseases by which the feeding is not possible through mouth. According to a report by European Pet Food Industry Federation, over 75 million households in Europe own a pet and according to American Veterinary Medical Association more than half of U.S. households own pets and only 18.7 percent did not take their dog or dogs to a veterinarian. When animals get diseases like pancreatitis the feeding is not possible then these intravenous solutions are helpful to feed them. Increase in the demand for more nutritious food is anticipated to propel the global artificial joints market over the forecast years.
North America accounted for larger revenue share in global veterinary intravenous solutions market with significant CAGR owing to increasing number of pets in the houses, availability of advanced veterinary health care, rise in interest towards the disease prevention for the animals and limited natural source to feed the animals in the region are expected to increase the growth of the market over the forecasted years. Asia Pacific region are expected to grow at a significant growth rate over the forecast years owing to the increase in cattle rearing due to increase in demand for the milk and wool, government initiatives to rear cattle, government subsidies for animal rearing and the trend of owing pets.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 11.8 billion |
|
Market CAGR |
8% |
|
By Product Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The veterinary intravenous solutions market is projected to expand at a CAGR of 8% during the forecast period.
Aspen Vet, Merck & Co., Inc. (MSD Veterinary Manual), Dechra Veterinary Products, Pfizer, Inc., Sypharma
North America is the fastest-growing region for veterinary intravenous solutions market
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.